Complications of Permanent Cardiac Pacing;Complications de la Stimulation Cardiaque Définitive

Archives des Maladies du Coeur et des Vaisseaux

Volumn 96, Issue SPEC. ISS. 7, 2003, Pages 46-53

  Klug, D ^b   Marquie C ^b   Lacroix, D ^b   Kacet, S ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGY; CONFERENCE PAPER; HEART ATRIUM ARRHYTHMIA; HEART CATHETER; HEART HEMODYNAMICS; HEART LEFT VENTRICLE; HEART PACING; HEMATOMA; HEMODYNAMIC MONITORING; HUMAN; INFECTION; MEDICAL DECISION MAKING; PNEUMOTHORAX; RISK BENEFIT ANALYSIS; SUDDEN DEATH; SUPERIOR CAVA VEIN SYNDROME; THROMBOSIS; TREATMENT INDICATION; TREATMENT PLANNING; VEIN DISEASE;

CARDIOVASCULAR DISEASES; EQUIPMENT DESIGN; EQUIPMENT FAILURE; HUMANS; PACEMAKER, ARTIFICIAL; PROSTHESIS-RELATED INFECTIONS;

EID: 1542350128     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (65)

1. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000; 133: 604-8.
2. Moss AJ, Hall WJ, Cannom DS et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933-40.
3. Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-83.
4. Lee KL, Hafley G, Fisher JD et al. Effect of implantable defibrillators on arrhythmic events and mortality in the multicenter unsustained tachycardia trial. Circulation 2002; 106: 233-8.
5. Cazeau S, Leclercq C, Lavergne T et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344: 873-80.
6. Aggarwal RK, Connelly DT, Ray SG, Ball J, Charles RG. Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems. Br Heart J 1995; 73: 571-5.
7. Kran J, Herre J, Renfrae EG et al. Lead- and device-related complications in the antiarrhythmics versus implantable defibrillators trial. Am Heart J 2001; 141: 92-8.
8. Harcombe AA, Newell SA, Ludman PF et al. Late complications following permanent pacemaker implantation or elective unit replacement. Heart 1998; 80: 240-4.
9. Maisel WH, Sweeney MO, Stevenson WG, Ellison KE, Epstein LM. Recalls and safety alerts involving pacemakers and implantable cardiaverter-defibrillator generators. JAMA 2001; 286: 793-9.
10. Boxall J. Safety alert on the ACCUFIX otrial "J" pacemaker. Pacing Clin Electrophysiol 1999; 22: 403.
11. Kay GN, Brinker JA, Kawanishi DT et al. Risks of spontaneous injury and extraction of an active fixation pacemaker lead: report of the Accufix Multicenter Clinical Study and Worldwide Registry. Circulation 1999; 100: 2344-52.
12. Furman S. Recall by Telectronics Pacing Systems of all unimplanted Accufix otrial "J" pacemaker leads, models 330-801. Pacing Clin Electrophysiol 1995; 18: 375.
13. Rankin JM, Davis MJ. Protrusion of retention wire from EncorDec passive fixation atrial pacing lead. Lancet 1995; 346: 1169-70.
14. Barakat K, Robinson NM, Spurrell RA. Transvenous pacing lead-induced thrombosis: a series of cases with a review of the literature. Cardiology 2000; 93: 142-8.
15. Zuber M, Huber P, Fricker U, Buser P, Jager K. Assessment of the subclavian vein in patients with transvenous pacemaker leads. Pacing Clin Electrophysiol 1998; 21: 2621-30.
16. Mustafa S, Stein PD, Patel KC, Otten TR, Holmes R, Silbergleit A. Upper extremity deep venous thrombosis. Chest 2003; 123: 1953-6.
17. Sakakibara Y, Shigeta O, Ishikawa S et al. Upper extremity vein thrombosis: etiologic categories, precipitating causes and management. Angiology 1999; 50: 547-53.
18. Chow BJ, Hassan AH, Chan KL, Tong AS. Prevalence and significance of lead-related thrombi in patients with implantable cardioverter defibrillators. Am J Cardiol 2003; 91: 88-90.
19. Kappenberger L, Linde C, Daubert C et al. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. Eur Heart J 1997; 18: 1249-56.
20. Prinzen FW, Peschar M. Relation between the pacing induced sequence of activation and left ventricular pump function in animals. Pacing Clin Electrophysiol 2002; 25: 484-98.
21. Le Tourneau T, Klug D, Lacroix D. Mitral valve replacement for pacing-induced severe mitral regurgitation after radiofrequency ablation of the atrioventricular junction. Heart 1996; 76: 457.
22. Cannan CR, Higano ST, Holmes DR Jr. Pacemaker induced mitral regurgitation: an alternative form of pacemaker syndrome. Pacing Clin Electrophysiol 1997; 20: 735-8.
23. Hanna SR, Chung ES, Aurigemma GP, Meyer TE. Warsening of mitral regurgitation secondary to ventricular pacing. J Heart Valve Dis 2000; 9: 273-5.
24. Nunez A, Alberca MT, Cosio FG et al. Severe mitral regurgitation with right ventricular pacing, successfully treated with left ventricular pacing. Pacing Clin Electrophysiol 2002; 25: 226-30.
25. Sassone B, De Simone N, Parlangeli G, Tortorici R, Bioncoli S, Di Pasquale G. Pacemaker-induced mitral regurgitation: prominent role of abnormal ventricular activation sequence versus altered atrioventricular synchrony. Ital Heart J 2001; 2: 441-8.
26. Anguera I, Brugada J, Brugada P et al. [Hemodynamic deterioration in patients submitted to ablation of the atrioventricular node]. Rev Esp Cardiol 1998; 51: 307-13.
27. Wilkoff BL, Cook JR, Epstein AE et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002; 288: 3115-23.
28. Sweeney MO, Hellkamp AS, Ellenbogen KA et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003; 107: 2932-7.
29. Samet P, Castillo C, Bernsein WH. Hemodynamic consequences of sequential atrioventricular pacing. Subjects with normal hearts. Am J Cardiol 1968; 21: 207-12.
30. Prinzen FW, Van Oosterhaut MF, Vanagt WY, Storm C, Reneman RS. Optimization of ventricular function by improving the activation sequence during ventricular pacing. Pacing Clin Electrophysiol 1998; 21: 2256-60.
31. Galdman DS, Levine PA. Pacemaker-mediated polymorphic ventricular tachycardia. Pacing Clin Electrophysiol 1998; 21: 1993-5.
32. Himmrich E, Przibille O, Zellerhaff C et al. Proarrhythmic effect of pacemaker stimulation in patients with implanted cardioverter-defibrillators. Circulation 2003; 108: 192-7.
33. Zehender M, Buchner C, Meinertz T, Just H. Prevalence, circumstances, mechanisms, and risk stratification of sudden cardiac death in unipolar single-chamber ventricular pacing. Circulation 1992; 85: 596-605.
34. Gold MR, Brockman R, Peters RW, Olsovsky MR, Shorofsky SR. Acute hemodynamic effects of right ventricular pacing site and pacing mode in patients with congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2000; 85: 1106-9.
35. Bluhm G. Pacemaker infections. A clinical study with special reference to prophylactic use of same isoxozolyl penicillins. Acta Med Scand Suppl 1985; 699: 1-62.
36. Frame R, Brodman RF, Furman S, Andrews CA, Gross JN. Surgical removal of infected transvenous pacemaker leads. Pacing Clin Electrophysiol 1993; 16: 2343-8.
37. Bluhm GL. Pacemaker infections. A 2-year follow-up of antibiotic prophylaxis. Scand J Thorac Cardiovasc Surg. 1985; 19: 231-5.
38. Hill PE. Complications of permanent transvenous cardiac pacing: a 14-year review of all transvenous pacemakers inserted at one community hospital. Pacing Clin Electrophysiol 1987; 10: 564-70.
39. Lau JM, Guinn GA, Beall AC, Jr., Mattox KL, Young JB, DeBakey ME. Operative techniques in infective endocarditis. Ann Thorac Surg 1981; 32: 351-6.
40. Wade JS, Cabbs CG. Infections in cardiac pacemakers. Curr Clin Top Infect Dis 1988; 9: 44-61.
41. Smith PN, Vidaillet HJ, Hayes JJ et al. Infections with nonthoracotomy implantable cardioverter defibrillators: can these be prevented? Endotak Lead Clinical Investigators. Pacing Clin Electrophysiol 1998; 21: 42-55.
42. Kearney RA, Eisen HJ, Wolf JE. Nonvalvular infections of the cardiovascular system. Ann Intern Med 1994; 121: 219-30.
43. Abraham WT, Fisher WG, Smith AL et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-53.
44. Da Costa A, Lelievre H, Kirkorian G et al. Role of the preaxillary flara in pacemaker infections: a prospective study. Circulation 1998; 97: 1791-5.
45. Klug D, Vaksmann G, Jarwe M et al. Pacemaker lead infection in young patients. Pacing Clin Electrophysiol 2003; 26: 1489-1493.
46. Love CJ, Wilkoff BL, Byrd CI et al. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: indications, facilities, training. North American Society of Pacing and Electrophysiology Lead Extraction Conference Faculty. Pacing Clin Electrophysiol 2000; 23: 544-51.
47. Jara FM, Toledo-Pereyra L, Lewis JW, Jr, Magilligan DJ Jr. The infected pacemaker pocket. J Thorac Cardiovasc Surg 1979; 78: 298-300.
48. Baddour LM. Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am J Med Sci 2001; 322: 209-12.
49. Lee JH, Geha AS, Rattehalli NM et al. Salvage of infected ICDs: management without removal. Pacing Clin Electrophysiol 1996; 19: 437-42.
50. Har-Shai Y, Amikam S, Bolous M, Peled U. The management of soft tissue complications related to pacemaker implantations. J Cardiovasc Surg (Torino) 1994; 35: 211-7.
51. Har-Shai Y, Amikam S, Ramon Y, Kahir G, Hirshowitz B. The management of exposed cardiac pacemaker pulse generator and electrode using restricted local surgical interventions; subcapsular relocation and vertical-to-horizontal bow transposition techniques. Br J Plast Surg 1990; 43: 307-11.
52. Yamada M, Takeuchi S, Shiojiri Y et al. Surgical lead-preserving procedures for pacemaker pocket infection. Ann Thorac Surg 2002; 74: 1494-9; discussion 1499.
53. Hayes DL, Loesl K. Pacemaker component allergy: case report and review of the literature. J Interv Card Electrophysiol 2002; 6: 277-8.
54. Iguchi N, Kasanuki H, Matsuda N, Shodo M, Ohnishi S, Hosoda S. Contact sensitivity to polychloroparaxylene-coated cardiac pacemaker. Pacing Clin Electrophysiol 1997; 20: 372-3.
55. Moini C, d'Alteroche A, Cosnay P et al. Contact dermatitis following cardiac pacemaker implantation. Arch Mal Cœur 1996; 89: 253-6.
56. Abdallah HI, Balsara RK, O'Riordan AC. Pacemaker contact sensitivity: clinical recognition and management. Ann Thorac Surg 1994; 57: 1017-8.
57. Hartstein AI, Jackson J, Gilbert DN. Prophylactic antibiotics and the insertion of permanent transvenous cardiac pacemakers. J Thorac Cordiavasc Surg 1978; 75: 219-23.
58. Muers MF, Arnold AG, Sleight P. Prophylactic antibiotics for cardiac pacemaker implantation. A prospective trail. Br Heart J 1981; 46: 539-44.
59. Jacobson B, Bluhm G, Julander I, Nord CE. Caagulase-negative staphylococci and cloxacillin prophylaxis in pacemaker surgery. Acta Pathol Microbiol Immunol Scand [B] 1983; 91: 97-9.
60. Ramsdale DR, Charles RG, Rowlands DB, Singh SS, Gautam PC, Faragher EB. Antibiotic praphylaxis far pacemaker implantation: a prospective randomized trial. Pacing Clin Electrophysiol 1984; 7: 844-9.
61. Parsonnet V, Bernstein AD, Lindsay B. Pacemaker-implantation complication rates: an analysis of same contributing factors. J Am Coll Cardiol 1989; 13: 917-21.
62. De Lalla F, Bonini W, Broffoni T, Ferrari G, Alegente G. Prophylactic mezlocillin-netilmicin combination in permanent transvenous cardiac pacemaker implantation: a single-center, prospective randomized study. J Chemother 1990; 2: 252-6.
63. Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and submuscular approaches. Worldwide Jewel Investigators. J Am Coll Cardiol 1996; 28: 1278-82.
64. Kiviniemi MS, Pirnes MA, Eranen HJ, Kettunen RV, Hartikainen JE. Complications related to permanent pacemaker therapy. Pacing Clin Electrophysiol 1999; 22: 711-20.
65. Mela T, McGovern BA, Garan H et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter-defibrillator implants. Am J Cardiol 2001; 88: 750-3.